A Look at Novanta Inc (NOVT) After 3.1% Gain -- GF Value $154.22 vs Price $159.70
On May 22, 2026, Novanta Inc (NOVT) shares rose 3.1% to $159.70, reflecting a positive price movement amid a strong performance over the past month and year. Th
NOVT - Novanta Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$150.00
DETAILS
HIGH:
$150.00
LOW:
$150.00
MEDIAN:
$150.00
CONSENSUS:
$150.00
DOWNSIDE:
6.07%
Stock News
A Look at Novanta Inc (NOVT) After 4.0% Gain -- GF Value $154.26 vs Price $153.60
On May 20, 2026, Novanta Inc (NOVT) shares rose 4.0% today, bringing the current price to $153.60. The stock has experienced a 52-week range of $98.27 to $165.5
Here's Why Novanta (NOVT) Looks Ripe for Bottom Fishing
Novanta (NOVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive.
Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.
Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript
Novanta Inc. (NOVT) Q1 2026 Earnings Call Transcript
Novanta Q1 Earnings Call Highlights
Novanta NASDAQ: NOVT reported stronger-than-expected first-quarter 2026 results, with management citing broad-based bookings growth, accelerating demand in automation and medical markets, and rising exposure to artificial intelligence-related infrastructure applications.
Novanta (NOVT) Q1 Earnings and Revenues Surpass Estimates
Novanta (NOVT) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.74 per share a year ago.
Novanta Announces Financial Results for the First Quarter 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) April 3, March 28, 2026 2025 GAAP Revenue $ 257.7 $ 233.4 Operating Income $ 27.5 $ 32.4 Net Income $ 21.1 $ 21.2 Diluted EPS $ 0.51 $ 0.5.
Novanta Inc (NOVT) Shares Fall 6.3% -- What GF Score of 92 Tells Investors
On April 29, 2026, Novanta Inc (NOVT) shares fell 6.3% to $120.89. This decline comes amid a 52-week range of $98.27 to $149.95, reflecting notable volatility.
Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference c.
Novanta Inc. $NOVT Shares Acquired by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC increased its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 75.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,399,462 shares of the technology company's stock after purchasing an additional 604,055
Congress Asset Management Co. Has $72.82 Million Position in Novanta Inc. $NOVT
Congress Asset Management Co. raised its stake in Novanta Inc. (NASDAQ: NOVT) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 611,978 shares of the technology company's stock after buying an additional 21,331 shares during the quarter. Congress
Novanta Joins NVIDIA Halos AI Systems Inspection Lab
BOSTON--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) announced today that it has joined NVIDIA Halos AI Systems Inspection Lab, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. The lab helps accelerate certification and advance trust in key components and subsystems enabling the next generation of robotics and physical AI systems. By participating in Halos AI Systems Inspection Lab, Novanta will work with NVIDIA to validate the interop.
Capital International Investors Sells 620,843 Shares of Novanta Inc. $NOVT
Capital International Investors reduced its stake in shares of Novanta Inc. (NASDAQ: NOVT) by 82.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,552 shares of the technology company's stock after selling 620,843 shares during the quarter. Capital
Blair William & Co. IL Decreases Stock Holdings in Novanta Inc. $NOVT
Blair William and Co. IL lessened its holdings in Novanta Inc. (NASDAQ: NOVT) by 48.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 132,427 shares of the technology company's stock after selling 126,931 shares during the period. Blair William
Novanta Stock Has Underperformed This Past Year, but One Investor Just Made a $36 Million Bet on Shares
Harvey Partners bought 304,000 shares of Novanta in the fourth quarter. The quarter-end position value increased by $36.17 million as a result.
Is Novanta Stock a Buy or Sell After Its CEO Dumped 7,500 Shares Worth $1.1 Million?
CEO Matthijs Glastra sold 7,500 shares for a transaction value of ~$1.09 million on Feb. 10, 2026. This sale represented 6.29% of total holdings at the time.
Bradley Foster & Sargent Inc. CT Increases Stake in Novanta Inc. $NOVT
Bradley Foster and Sargent Inc. CT increased its stake in Novanta Inc. (NASDAQ: NOVT) by 10.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,172 shares of the technology company's stock after purchasing an additional 6,128 shares during the period.
Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript
Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript
Price Targets
Novanta price target raised to $150 from $138 at Baird
$150.00
(was $134.67)
Robert Mason
·
Robert W. Baird
Novanta price target lowered to $160 from $169 at Baird
$160.00
(was $143.37)
Robert W. Baird
Novanta price target raised to $175 from $170 at Baird
$175.00
(was $174.36)
Robert Mason
·
Robert W. Baird